Sunshine Biopharma Inc. SEC filings SBFM
Sunshine Biopharma Inc. has 428 filings in SEC EDGAR's recent list, going back to May 25, 2007. Its latest annual report, Form 10-K, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 11, 2026 | Aug 7, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 8, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 22, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 21, 2026 | — |
| 4 | Insider transaction | Apr 14, 2026 | Apr 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 12, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 23, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 3 | Initial insider ownership | Jan 21, 2025 | Jan 13, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Mar 5, 2024 | Mar 4, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 23, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 21, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 9, 2024 | Jan 26, 2024 |
| 4 | Insider transaction | Dec 2, 2022 | Nov 30, 2022 |
| SC 13G | Ownership over 5% (passive) | Nov 2, 2022 | — |
| 3 | Initial insider ownership | Oct 26, 2022 | Oct 20, 2022 |
| 4 | Insider transaction | Jun 6, 2022 | Jun 3, 2022 |
| 4 | Insider transaction | Feb 22, 2022 | Feb 18, 2022 |
| 3 | Initial insider ownership | Feb 18, 2022 | Feb 10, 2022 |
| 3 | Initial insider ownership | Feb 18, 2022 | Feb 10, 2022 |
| 3 | Initial insider ownership | Dec 16, 2021 | Oct 31, 2021 |
| 3 | Initial insider ownership | Dec 14, 2021 | Oct 31, 2021 |
| 3 | Initial insider ownership | Dec 9, 2021 | Oct 31, 2021 |
| SC 13G | Ownership over 5% (passive) | Jul 29, 2021 | — |
| 4 | Insider transaction | Feb 16, 2021 | Jan 6, 2021 |
| 4 | Insider transaction | Feb 16, 2021 | Jan 6, 2021 |
| 4 | Insider transaction | Feb 16, 2021 | Jan 6, 2021 |
| 4 | Insider transaction | Jul 15, 2020 | Sep 11, 2019 |
| 4 | Insider transaction | Jul 13, 2020 | Oct 20, 2019 |
| 4 | Insider transaction | Jul 10, 2020 | Oct 20, 2019 |
| 4 | Insider transaction | Jun 25, 2020 | Jun 17, 2020 |
| 4 | Insider transaction | Oct 7, 2019 | Sep 2, 2019 |
| 4/A | Primary document | Oct 7, 2019 | Aug 27, 2018 |
| 4/A | Primary document | Oct 7, 2019 | Jun 20, 2018 |
| 4/A | Primary document | Oct 4, 2019 | Jul 20, 2017 |
| 4/A | Primary document | Oct 4, 2019 | Dec 6, 2016 |
| 4/A | Primary document | Oct 4, 2019 | Apr 22, 2016 |
| 3/A | Primary document | Oct 4, 2019 | Feb 20, 2015 |
| 4 | Insider transaction | Sep 23, 2019 | Sep 2, 2019 |
| 4 | Insider transaction | Sep 23, 2019 | Sep 2, 2019 |
| 4 | Insider transaction | Sep 14, 2018 | Aug 27, 2018 |
| 4 | Insider transaction | Sep 14, 2018 | Aug 27, 2018 |
| 4 | Insider transaction | Sep 14, 2018 | Aug 27, 2018 |
| 4 | Insider transaction | Jun 28, 2018 | Jun 20, 2018 |
| 4 | Insider transaction | Jun 28, 2018 | Jun 20, 2018 |
| 4 | Insider transaction | Jun 28, 2018 | Jun 20, 2018 |
| 4 | Insider transaction | Sep 8, 2017 | Jul 20, 2017 |
| 4 | Insider transaction | Sep 8, 2017 | Jul 20, 2017 |
| 4 | Insider transaction | Sep 8, 2017 | Jul 20, 2017 |
| 4 | Insider transaction | Dec 15, 2016 | Dec 6, 2016 |
| 4 | Insider transaction | Dec 15, 2016 | Dec 6, 2016 |
| 4 | Insider transaction | Dec 15, 2016 | Dec 6, 2016 |
| 4 | Insider transaction | Nov 7, 2016 | Oct 10, 2016 |
| 4 | Insider transaction | Nov 7, 2016 | Oct 10, 2016 |
| 4 | Insider transaction | Nov 7, 2016 | Oct 10, 2016 |
| 3 | Initial insider ownership | Aug 2, 2016 | Jul 8, 2016 |
| 4 | Insider transaction | Aug 1, 2016 | Jul 8, 2016 |
| 4 | Insider transaction | Apr 26, 2016 | Apr 12, 2016 |
| 4 | Insider transaction | Apr 25, 2016 | Apr 22, 2016 |
| 4 | Insider transaction | Apr 25, 2016 | Apr 22, 2016 |
| 4 | Insider transaction | Jun 1, 2015 | May 27, 2015 |
| 3 | Initial insider ownership | Mar 20, 2015 | Feb 20, 2015 |
| 4 | Insider transaction | Mar 20, 2015 | Feb 20, 2015 |
| 4 | Insider transaction | Jan 22, 2015 | Jan 9, 2015 |
| 4/A | Primary document | Oct 5, 2012 | Dec 21, 2011 |
| 4 | Insider transaction | Sep 7, 2012 | Dec 21, 2011 |
| 3 | Initial insider ownership | Nov 2, 2009 | Oct 15, 2009 |
| 3 | Initial insider ownership | Nov 2, 2009 | Oct 15, 2009 |
| 3 | Initial insider ownership | Nov 2, 2009 | Oct 15, 2009 |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SBFM (Nasdaq), SBFMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1402328
- Former names
- Sunshine Biopharma, Inc (until Oct 17, 2024); Mountain West Business Solutions, Inc (until Nov 2, 2009); mountain west business solutions,inc (until Oct 19, 2007); mountain state business solutions,inc (until May 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.